Re: Longs to become CVS?
One businessman who is a stockholder and whose opinion probably matters more than others, is Bill Ackman of Pershing Square. Apparently, Ackman recently acquired an 8.8% stake in Longs Drugs, and in an interview on CNBC, gives his perspective on what he describes as an “interesting opportunity.”
Originally posted by anapuni808
View Post
Comment